Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Liabilities and Shareholders Equity (2016 - 2025)

GeoVax Labs' Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $6.3 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $6.3 million for Q4 2025, down 22.24% from a year ago — trailing twelve months through Dec 2025 was $29.3 million (up 9.49% YoY), and the annual figure for FY2025 was $6.3 million, down 22.24%.
  • Liabilities and Shareholders Equity for Q4 2025 was $6.3 million at GeoVax Labs, down from $6.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $38.6 million in Q3 2022 to a low of $3.4 million in Q1 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $14.0 million (2021), against an average of $16.1 million.
  • The sharpest move saw Liabilities and Shareholders Equity soared 2441.48% in 2021, then crashed 87.75% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $11.8 million in 2021, then soared by 165.73% to $31.3 million in 2022, then plummeted by 70.39% to $9.3 million in 2023, then decreased by 12.14% to $8.2 million in 2024, then dropped by 22.24% to $6.3 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $6.3 million, $6.7 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.